Lumbricus rubellus earthworm as an antibacterial: A systematic review

Earthworms, Lumbricus rubellus, have a long history of medicinal use as adjuvant therapy or alternative medicine in a range of diseases including typhoid fever, infection of Staphylococcus , and dermatitis. The anti-bacterial effect of L. rubellus has been proven in many scientific studies, and some of the traditional applications of earthworms as a home remedy have been confirmed in humans. In this systematic review, we summarized the current evidence on the antimicrobial effects of L. rubellus against bacteria. Electronic databases including Science Direct, Wiley Online Library, Academic Search Complete, PubMed, Directory of Open Access Journal, Cochrane Library, and Indonesian Publication Index were searched for relevant studies published until October 2022, as well as direct contact with specific researchers reporting the effect of L. rubellus as an antibacterial. This review identified 17 studies that met the inclusion criteria. Fifteen studies show the antibacterial effect of L. rubellus has broad-spectrum antimicrobial peptides against Gram-negative and positive bacteria. The findings suggest that L. rubellus can be used as an alternative to antibiotics. Further high-quality clinical trials should be conducted to provide information about the long-term effectiveness and ability of antibacterial agents of L. rubellus.


INTRODUCTION
The excessive use of antibiotics and intrinsic changes of (gene expression changes) in bacteria has increased antimicrobial resistance (AMR).In 2019, The World Health Organization released that AMR is 1 of 10 warnings to global health.It can affect clinical, economic, and death losses, especially in developing countries (Aslam et al., 2018;Foekh et al., 2019).Infection with AMR causes severe illnesses, prolonged length of stay in the hospital, increases in healthcare costs, and the higher cost of second-line drugs and treatment failures.Centers for disease control and prevention released that AMR adds a 20 billion dollar surplus in health costs in the United States and caused 23,000 deaths per year and 2.5 months extra hospital days, while in Europe, more than 9 billion euros per year spent on AMR and caused more than 25,000 deaths per year and 2.5 months additional hospital days (Dadgostar, 2019).
AMR has triggered researchers to find new alternative drug ingredients that can act as antibiotics from nature.One of the natural materials that could be used as an antibiotic is earthworms.Earthworms have been used as a traditional medicine for 100 years.Only a few species can be used as medicine.Lumbricus rubellus is one of them.Lumbricus rubellus extract comprises antibacterial characteristics and could inhibit Gram-positive and Gram-negative bacteria (Foekh et al., 2019;Sun, 2015).Lumbricus rubellus has an antimicrobial peptide (AMP) called lumbricin-I, which plays a vital role in natural defense against pathogenic microbes.Lumbricin-I was a proline-rich AMP of 62 amino acids.Lumbricin-I represented antimicrobial action in vitro against a broad spectrum of microorganisms and fungi without hemolytic side effects.This peptide leads to the establishment of multimeric pores in the bacterial cell wall.It causes the cytoplasm of bacterial cells to be exposed to the outside environment causing bacterial death.Lumbricin-I found in adult L. rubellus (Cho et al., 1998).Several studies on the use of L. rubellus extract as an alternative drug to treat infectious diseases such as typhoid fever (Lestari et al., 2019;Purwitanto et al., 2013), periapical infection (Andayani et al., 2016) periodontitis (Dharmawati et al., 2019), and pullorum disease in poultry (Damayanti et al., 2009).There has been no systematic review to date to evaluate the evidence of the antibiotic property of earthworm extract.We, therefore, conducted a systematic review of the available literature on L. rubellus as an antibacterial.We analyzed the effect of L. rubellus as an antibacterial on a comprehensive and heterogenous range of bacteria to evaluate its effectiveness and safety.

Objectives
The objective of this study was to assess the evidence from previous studies on the use of L. rubellus as an antibacterial agent.

Protocol
We followed the preferred reporting items for systematic reviews and meta-analyses guidelines (Liberati et al., 2009).

Data sources and search strategy
Searches were performed in Science Direct (1998-2022), Wiley Online Library (1892-2022), Academic Search Complete (1983-2022), PubMed (1973-2022), Directory of Open Access Journal (1990-2022), Cochrane Library (2018-2022), Indonesian Publication Index (2012-2022), and direct contact the specific researcher with keywords "Lumbricus rubellus".We included all research types (in vitro study, animal study or clinical trial) published in English and Indonesian up to October 2022.A selection of relevant studies based on title and abstract, then the selected article is downloaded and reviewed by the author.The available data were extracted and tabled (Table 1).We excluded literature on L. rubellus as other agents such as antipyretic, antithrombotic, antiaging, and duplicate records.

Outcome
Our primary outcome of this systematic review was the effect of L. rubellus as an antibacterial.

Risk of bias assessment
The risk of bias was assessed by the Cochrane Risk of Bias tools.There was only one clinical trial evaluation performed.

RESULTS
The literature searches identified 2,567 studies, of which 57 articles were excluded as duplicates between databases.The title and abstract were reviewed and yielded 23 articles that were reviewed in full text; of these, six were excluded, and 17 articles met the inclusion criteria (Fig. 1).
2. A cell suspension containing 1 × 10 6 bacterial CFUs was added to 6 ml of underlayer agar broth and the mixture was poured into a petri dish.Incubated overnight at 37°C.Antimicrobial activity was examined by minimal inhibitory concentrations.
Lumbricin I was approximately three times more potent against tested bacteria.Lumbricin I (6-34) showed stronger antimicrobial activity than lumbricin I.

Escherichia coli
Escherichia coli inoculated into 20 ml NA media.
Lumbricus rubellus is capable to inhibit E. coli at optimum level of 50% and significantly higher than 25%, 75%, and 100% concentration.

3.
Damayanti et al. ( In Lumbricus rubellus has antibacterial properties by significantly reducing bacterial colonies of S. thypimurium in male Wistar rats.

Muchtaromah et al. (2019)
Animal study Small intestine and kidney of white rats infected with S. thypi Administration of L. rubellus powder with various concentrations (32%, 48%, and 60%) and administration (7 and 14 days) of earthworm powder.The worm powder affects improving the histological picture of the small intestine and kidneys of white rats (R. norvegicus).
The effective treatment was found at a concentration of 60%, with a duration of 14 days.

16.
Dharmawati et al. ( In vitro study Phorphyromonas gingivalis The P. gingivalis was swabbed on the surface of media agar. The paper discs containing different concentrations of L. rubellus (50%; 25%; 12.5%; and 6.25%) were placed on the agar surface, then incubated at 37°C for 24 hours.
Lumbricus rubellus can inhibit the growth of P. gingivalis bacteria from 12.5% concentration and 50% has the largest diameter of the inhibitory zone on the growth of the P. gingivalis bacteria.

17.
Ulhaq et al.L. rubellus extract thrice daily and 400 mg ciprofloxacin twice daily.In the control group, 26 samples were treated with 400 mg of ciprofloxacin twice daily and a placebo thrice daily.In both groups treated for 7 days, there was no significant difference in loss of fever (p = 0.896), using antipyretic (p = 0.159), amount of leukocytes (p = 0.484), amount of hemoglobin (p = 0.984), and the total of thrombocytes (p = 0.657) (Purwitanto et al., 2013).

DISCUSSION
This study aimed to review the antibacterial effect of L. rubellus and to gain further and specific conclusions about the mechanism of action of L. rubellus as an antibacterial agent.Most researchers have reported promising results for L. rubellus as an antibacterial agent from a literature review.However, we still found two studies that did not support this finding (Ekasari et al., 2012;Purwitanto et al., 2013).
Eathworm of L. rubellus contains peptides with board spectrum antimicrobial activity known as lumbricin-I (formed by 62 amino acids and having a measurement of 7,231 Da).It has a proline that includes a conformational structure that influences the secondary system and then represents the mechanism of action.Besides lumbricin-I, certain AMPs have the same design with proline-rich, such as apidaecins, drosocin, metchikowin, bactenecins, and PR-39 but show various mechanisms of action.The mechanism of action of lumbricin-I in inhibiting pathogens remains unclear.However, there was one hypothesis that presents a different tool from other proline-rich AMPs (Cho et al., 1998).The mechanism of action of AMPs begins with the first interaction between the peptide and the target cell (bacteria or fungi) due to the impact of electrostatic power.Cationic is an essential factor that plays a vital role in electrostatic interactions between AMPs and the negatively charged phospholipid membrane of bacteria.The permeability of the cell membrane is assumed can be influenced by the exchange of cation (AMP) and anions (bacteria and fungi cell surface) and cause cell damage so that lumbricin-I can pierce the cytoplasmic membrane (Epand and Vogel, 1999;Jenssen et al., 2006).AMP cationic has a positive correlation with antimicrobial activity.The higher cationicity strongly influences antimicrobial activity (Yeaman and Yount, 2003).Another effectiveness of lumbricin-I as an antimicrobial is evidenced by the interaction between the hydrophobic surface and the hydrophilic surface of the bacterial cell membrane.It causes an increase in membrane permeability so that the lumbricin-I can enter the hydrophilic lipid layer.The entry of lumbricin-I into the intracellular cell membrane causes intracellular instability and inhibits bacterial growth (Pasupuleti et al., 2009).
The study by Purwitanto et al. (2013) reported that the addition of L. rubellus extract on ciprofloxacin had no effect on leukocyte count in typhoid fever patient (p = 0.484).This study did not assess the effect of pure L. rubellus extract as antibacterial but was seen from the addition of L. rubellus extract in the primary therapy, ciprofloxacin.The antibacterial activity of L. rubellus can cause a negative result from this study against S. typhi, not synergy with ciprofloxacin, and the dose of L. rubellus maybe not be the optimal dose because an optimal dose of L. rubellus remains unclear.Lumbricus rubellus has antithrombotic and thrombolytic effects in several studies.In this study, there were no reports of bleeding manifestations in the treatment group and no significant changes in hemoglobin and thrombocyte levels.The addition of earthworm extract to antibiotic treatment did not affect the duration of fever, gastrointestinal disturbances, leucocytes, liver function in typhoid patients, and incidence of side effects of treatment.The risk of bias in this clinical trial study is high because the sample is not entirely homogenous between the treatment and control groups.It can affect the results (Purwitanto et al., 2013).
Additionally, in this review, we found that S. aureus was the most sensitive bacteria in L. rubellus extract (Indrawati et al., 2013;Istiqomah et al., 2012;Mulyatno and Melinda, 2017).Staphylococcus aureus is a Gram-positive bacteria and more sensitive to bacterial compounds than Gram-negative bacteria due to the structure of the bacteria's cell walls.Gram-positive bacteria have a single layer of peptidoglycan arranged by tissue with many pores, so the lumbricin-I easy to enter the intracellular cell membrane and causes intracellular instability and inhibits bacterial growth (Istiqomah et al., 2012).
Finally, although the broad-spectrum antibacterial activity demonstrated by L. rubellus shows that lumbricin-I can be possibility developed as a potent antimicrobial agent.Still, this review cannot make definitive conclusions about the compelling form of L. rubellus nor the safety of L. rubellus.

CONCLUSION
Studies show the potential use of L. rubellus for various antibacterial agents.However, investigations that determine the effect of L. rubellus as an antibacterial are still limited.Future clinical studies are required to examine the impact of L. rubellus as an antibacterial agent.
MRSA Thirty female mice were randomly divided into six groups: 1. Negative control 2. Positive control 3. Infected mice treated with 2% mupirocin 125 mg diluted in 240 ml saline 4. Three different doses of 40-kDa protein of L. rubellus diluted in saline (1:10, 1:50, 1:100) The high dose of 40-kDa protein of L. rubellus was able to eradicate MRSA colonization as effectively as mupirocin.

Table 1 .
Main characteristics from the included studies.